| Display title | Chemistry:Revospirone |
| Default sort key | Revospirone |
| Page length (in bytes) | 2,392 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 805683 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image | Error creating thumbnail: Unable to save thumbnail to destination |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>MainAI5 |
| Date of page creation | 07:04, 6 March 2023 |
| Latest editor | imported>MainAI5 |
| Date of latest edit | 07:04, 6 March 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Revospirone (Bay Vq 7813) is an azapirone drug which was patented as a veterinary tranquilizer but was never marketed. It acts as a selective 5-HT1A receptor partial agonist. Similarly to other azapirones such as buspirone, revospirone produces 1-(2-pyrimidinyl)piperazine (1-PP) as an active metabolite... |
